NCT06490523

Brief Summary

The aim of this prospective physiological cohort study conducted in a medical intensive care unit (ICU) at Hospital del Mar in Barcelona, Spain, was to analyze the proportion of time spent within the "safe" range of respiratory effort (including esophageal pressure swing (ΔPes), respiratory muscular pressure (Pmus), and transdiaphragmatic pressure swing (ΔPdi)) in patients with acute hypoxemic respiratory failure (AHRF) undergoing invasive mechanical ventilation (IMV), during the active breathing phase in relation to ICU survival. The investigators hypothesized that AHRF patients on IMV with better outcome (i.e., ICU survivors) spend more time within the "safe" range of respiratory effort during the active breathing phase compared to non-survivors. AHRF patients on IMV were continuously monitored with esophageal and gastric manometry from the detection of the onset of respiratory effort for up to 7 days, or until extubation, or until death, whichever occurred first.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2022

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

June 25, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 8, 2024

Completed
Last Updated

November 20, 2024

Status Verified

June 1, 2024

Enrollment Period

2 years

First QC Date

June 25, 2024

Last Update Submit

November 18, 2024

Conditions

Outcome Measures

Primary Outcomes (6)

  • Proportion of time spent in different ranges of ΔPes (low, safe, and high) during the active breathing phase between the two groups

    The defined "safe" range for ΔPes was -5 to -10 cm H2O. Effort outside the defined "safe" range was categorized as "low" if it fell below the lower limit, or "high" if it exceeded the upper limit of the safe range for the variable.

    From the start the start of respiratory effort up to 7 days (or until extubation or death, if earlier)

  • Proportion of time spent in different ranges of Pmus (low, safe, and high) during the active breathing phase between the two groups

    The defined "safe" range for Pmus was 5 to 15 cm H2O. Effort outside the defined "safe" range was categorized as "low" if it fell below the lower limit, or "high" if it exceeded the upper limit of the safe range for the variable.

    From the start the start of respiratory effort up to 7 days (or until extubation or death, if earlier)

  • Proportion of time spent in different ranges of ΔPdi (low, safe, and high) during the active breathing phase between the two groups

    The defined "safe" range for ΔPdi was 3 to 12 cm H2O. Effort outside the defined "safe" range was categorized as "low" if it fell below the lower limit, or "high" if it exceeded the upper limit of the safe range for the variable.

    From the start the start of respiratory effort up to 7 days (or until extubation or death, if earlier)

  • Median value of ΔPes during the active breathing phase between the two groups

    To analyze the median value of ΔPes during the active breathing phase between the two groups in cm H20.

    From the start the start of respiratory effort up to 7 days (or until extubation or death, if earlier)

  • Median value of Pmus during the active breathing phase between the two groups

    To analyze the median value of Pmus during the active breathing phase between the two groups in cm H20.

    From the start the start of respiratory effort up to 7 days (or until extubation or death, if earlier)

  • Median value of ΔPdi during the active breathing phase between the two groups

    To analyze the median value of ΔPdi during the active breathing phase between the two groups in cm H20.

    From the start the start of respiratory effort up to 7 days (or until extubation or death, if earlier)

Secondary Outcomes (6)

  • The need for the use of venovenous (VV) extracorporeal membrane oxygenation (ECMO)

    From date of initiation of invasive mechanical ventilation until extubation or date of death from any cause, whichever came first, assessed up to 24 months

  • The need for the use of extracorporeal CO2 removal (ECCO2R)

    From date of initiation of invasive mechanical ventilation until extubation or date of death from any cause, whichever came first, assessed up to 24 months

  • The need for a Tracheostomy

    From date of initiation of invasive mechanical ventilation until extubation or date of death from any cause, whichever came first, assessed up to 24 months

  • Duration of invasive mechanical ventilation (IMV)

    From date of initiation of invasive mechanical ventilation until extubation or date of death from any cause, whichever came first, assessed up to 24 months

  • Intensive care Unit (ICU) Length of stay

    From date of ICU admission until date of ICU discharge or date of death from any cause, whichever came first, assessed up to 24 months

  • +1 more secondary outcomes

Study Arms (2)

ICU survivors

Acute hypoxemic respiratory failure patients on invasive mechanical ventilation who survive to ICU discharge

ICU non-survivors

Acute hypoxemic respiratory failure patients on invasive mechanical ventilation who do not survive to ICU discharge

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients aged 18 years or older who were admitted to the ICU and required invasive mechanical ventilation (IMV) for acute hypoxemic respiratory failure (AHRF) were eligible for the study. Patients were excluded if they had chest drains, a contraindication to esophageal catheterization (e.g., recent upper gastrointestinal surgery, bleeding esophageal varices), or a concomitant acute exacerbation of obstructive airways disease.

You may qualify if:

  • Acute hypoxemic respiratory failure patients requiring invasive mechanical ventialtion

You may not qualify if:

  • Presence of chest drains
  • Contraindication to esophageal catheterization (e.g., recent upper gastrointestinal surgery, bleeding esophageal varices)
  • Concomitant acute exacerbation of obstructive airways disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital del Mar

Barcelona, Catalonia, 08003, Spain

Location

Related Publications (17)

  • Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291.

    PMID: 26903337BACKGROUND
  • Telias I, Brochard LJ, Gattarello S, Wunsch H, Junhasavasdikul D, Bosma KJ, Camporota L, Brodie D, Marini JJ, Slutsky AS, Gattinoni L. The physiological underpinnings of life-saving respiratory support. Intensive Care Med. 2022 Oct;48(10):1274-1286. doi: 10.1007/s00134-022-06749-3. Epub 2022 Jun 12.

    PMID: 35690953BACKGROUND
  • Sklar MC, Madotto F, Jonkman A, Rauseo M, Soliman I, Damiani LF, Telias I, Dubo S, Chen L, Rittayamai N, Chen GQ, Goligher EC, Dres M, Coudroy R, Pham T, Artigas RM, Friedrich JO, Sinderby C, Heunks L, Brochard L. Duration of diaphragmatic inactivity after endotracheal intubation of critically ill patients. Crit Care. 2021 Jan 11;25(1):26. doi: 10.1186/s13054-020-03435-y.

    PMID: 33430930BACKGROUND
  • Yoshida T, Fujino Y, Amato MB, Kavanagh BP. Fifty Years of Research in ARDS. Spontaneous Breathing during Mechanical Ventilation. Risks, Mechanisms, and Management. Am J Respir Crit Care Med. 2017 Apr 15;195(8):985-992. doi: 10.1164/rccm.201604-0748CP.

    PMID: 27786562BACKGROUND
  • Yoshida T, Uchiyama A, Matsuura N, Mashimo T, Fujino Y. Spontaneous breathing during lung-protective ventilation in an experimental acute lung injury model: high transpulmonary pressure associated with strong spontaneous breathing effort may worsen lung injury. Crit Care Med. 2012 May;40(5):1578-85. doi: 10.1097/CCM.0b013e3182451c40.

    PMID: 22430241BACKGROUND
  • Goligher EC. Myotrauma in mechanically ventilated patients. Intensive Care Med. 2019 Jun;45(6):881-884. doi: 10.1007/s00134-019-05557-6. Epub 2019 Feb 11. No abstract available.

    PMID: 30741329BACKGROUND
  • Goligher EC, Brochard LJ, Reid WD, Fan E, Saarela O, Slutsky AS, Kavanagh BP, Rubenfeld GD, Ferguson ND. Diaphragmatic myotrauma: a mediator of prolonged ventilation and poor patient outcomes in acute respiratory failure. Lancet Respir Med. 2019 Jan;7(1):90-98. doi: 10.1016/S2213-2600(18)30366-7. Epub 2018 Nov 16.

    PMID: 30455078BACKGROUND
  • Goligher EC, Dres M, Fan E, Rubenfeld GD, Scales DC, Herridge MS, Vorona S, Sklar MC, Rittayamai N, Lanys A, Murray A, Brace D, Urrea C, Reid WD, Tomlinson G, Slutsky AS, Kavanagh BP, Brochard LJ, Ferguson ND. Mechanical Ventilation-induced Diaphragm Atrophy Strongly Impacts Clinical Outcomes. Am J Respir Crit Care Med. 2018 Jan 15;197(2):204-213. doi: 10.1164/rccm.201703-0536OC.

    PMID: 28930478BACKGROUND
  • Kondili E, Alexopoulou C, Xirouchaki N, Vaporidi K, Georgopoulos D. Estimation of inspiratory muscle pressure in critically ill patients. Intensive Care Med. 2010 Apr;36(4):648-55. doi: 10.1007/s00134-010-1753-4. Epub 2010 Jan 28.

    PMID: 20107765BACKGROUND
  • Mauri T, Yoshida T, Bellani G, Goligher EC, Carteaux G, Rittayamai N, Mojoli F, Chiumello D, Piquilloud L, Grasso S, Jubran A, Laghi F, Magder S, Pesenti A, Loring S, Gattinoni L, Talmor D, Blanch L, Amato M, Chen L, Brochard L, Mancebo J; PLeUral pressure working Group (PLUG-Acute Respiratory Failure section of the European Society of Intensive Care Medicine). Esophageal and transpulmonary pressure in the clinical setting: meaning, usefulness and perspectives. Intensive Care Med. 2016 Sep;42(9):1360-73. doi: 10.1007/s00134-016-4400-x. Epub 2016 Jun 22.

    PMID: 27334266BACKGROUND
  • Akoumianaki E, Maggiore SM, Valenza F, Bellani G, Jubran A, Loring SH, Pelosi P, Talmor D, Grasso S, Chiumello D, Guerin C, Patroniti N, Ranieri VM, Gattinoni L, Nava S, Terragni PP, Pesenti A, Tobin M, Mancebo J, Brochard L; PLUG Working Group (Acute Respiratory Failure Section of the European Society of Intensive Care Medicine). The application of esophageal pressure measurement in patients with respiratory failure. Am J Respir Crit Care Med. 2014 Mar 1;189(5):520-31. doi: 10.1164/rccm.201312-2193CI.

    PMID: 24467647BACKGROUND
  • Jonkman AH, Telias I, Spinelli E, Akoumianaki E, Piquilloud L. The oesophageal balloon for respiratory monitoring in ventilated patients: updated clinical review and practical aspects. Eur Respir Rev. 2023 May 17;32(168):220186. doi: 10.1183/16000617.0186-2022. Print 2023 Jun 30.

    PMID: 37197768BACKGROUND
  • Chiumello D, Consonni D, Coppola S, Froio S, Crimella F, Colombo A. The occlusion tests and end-expiratory esophageal pressure: measurements and comparison in controlled and assisted ventilation. Ann Intensive Care. 2016 Dec;6(1):13. doi: 10.1186/s13613-016-0112-1. Epub 2016 Feb 12.

    PMID: 26868503BACKGROUND
  • Goligher EC, Dres M, Patel BK, Sahetya SK, Beitler JR, Telias I, Yoshida T, Vaporidi K, Grieco DL, Schepens T, Grasselli G, Spadaro S, Dianti J, Amato M, Bellani G, Demoule A, Fan E, Ferguson ND, Georgopoulos D, Guerin C, Khemani RG, Laghi F, Mercat A, Mojoli F, Ottenheijm CAC, Jaber S, Heunks L, Mancebo J, Mauri T, Pesenti A, Brochard L. Lung- and Diaphragm-Protective Ventilation. Am J Respir Crit Care Med. 2020 Oct 1;202(7):950-961. doi: 10.1164/rccm.202003-0655CP.

    PMID: 32516052BACKGROUND
  • Carteaux G, Mancebo J, Mercat A, Dellamonica J, Richard JC, Aguirre-Bermeo H, Kouatchet A, Beduneau G, Thille AW, Brochard L. Bedside adjustment of proportional assist ventilation to target a predefined range of respiratory effort. Crit Care Med. 2013 Sep;41(9):2125-32. doi: 10.1097/CCM.0b013e31828a42e5.

    PMID: 23787397BACKGROUND
  • de Vries H, Jonkman A, Shi ZH, Spoelstra-de Man A, Heunks L. Assessing breathing effort in mechanical ventilation: physiology and clinical implications. Ann Transl Med. 2018 Oct;6(19):387. doi: 10.21037/atm.2018.05.53.

    PMID: 30460261BACKGROUND
  • Parrilla-Gomez FJ, Castellvi-Font A, Boutonnet V, Parrilla-Gomez A, Antolin Terreros M, Mestre Somoza C, Blanes Bravo M, Pratsobrerroca de la Rubia P, Martin-Lopez E, Marco S, Festa O, Brochard LJ, Goligher EC, Masclans Enviz JR. Association of Breathing Effort With Survival in Patients With Acute Respiratory Distress Syndrome. Crit Care Med. 2025 Oct 1;53(10):e1982-e1994. doi: 10.1097/CCM.0000000000006797. Epub 2025 Aug 5.

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Investigator

Study Record Dates

First Submitted

June 25, 2024

First Posted

July 8, 2024

Study Start

December 1, 2020

Primary Completion

November 30, 2022

Study Completion

November 30, 2022

Last Updated

November 20, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations